FDA approves handheld device to assess traumatic brain injury

The Food and Drug Administration recently approved Ahead 300, a handheld medical device that helps clinicians diagnose a traumatic brain injury.

The device's electroencephalography technology uses algorithms and machine learning to analyze patient data in various clinically relevant measures. The device then produces a digital report of the patient's results to help clinicians assess the injury.

BrainScope, based in Bethesda, Md., developed the device, which it hopes to launch in the coming months.

More articles on supply chain:

UPS testing drones for emergency medical supply deliveries
Intermountain Healthcare recognizes 4 suppliers for outstanding work
Mylan working on EpiPen formulation with longer shelf life

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.